Request for COVID Vaccine Prioritization

Life Science Washington submitted the letter below to theWashington Department of Health requesting that two groups of high-risk essential life science employees be prioritized for early access to COVID-19 vaccines.  Our letter is consistent with BIO and AdvaMed requests for prioritization in the CDC’s Advisory Council on Immunization Practices (ACIP) framework.

Access the letter here.

Posted on Updated:
Share:
Related Resources
  • Industry Reports
  • 2026

Washington State Life Science Investment Report – September 2026
  • Industry Reports
  • 2026

Washington State Life Science Investment Report – August 2026
  • Industry Reports
  • 2026

Washington State Life Science Investment Report – July 2026
  • Policy Blog
  • 2026

Policy Blog – August 31, 2026 – NSCEB Visits Seattle to Discuss U.S. Biotechnology Competitiveness

Last week, Life Science Washington, in partnership with Arzeda, hosted a Seattle field visit by the National Security Commission on Emerging Biotechnology (NSCEB) as part of its Biotech Across America Roadshow.  Established by Congress, NSCEB has spent the past several years examining what the United States must do to maintain its leadership in biotechnology, with particular attention to growing competition […]